2022
DOI: 10.1007/s00432-022-04194-9
|View full text |Cite
|
Sign up to set email alerts
|

Immunomodulatory effects of carbon ion radiotherapy in patients with localized prostate cancer

Abstract: Purpose Radiotherapy is one of the main local treatment modalities for prostate cancer, while immunosuppressive effect induced by radiotherapy is an important factor of radiation resistance and treatment failure. Carbon ion radiotherapy (CIRT) is a novel radiotherapy technique and the immunomodulatory effect of CIRT provides the possibility of overcoming radioresistance and improving efficacy. The aim of this study was to assess the immune response evoked by CIRT in localized prostate cancer pati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 43 publications
0
7
1
Order By: Relevance
“… 24 Although the reason for this outcome was not determined in this study, peripheral immune activation after CIRT may be responsible. 25 Despite differences in background and evaluation methods between the previous studies and our study, our findings indicate that CIRT could be a promising treatment option for nmCRPC. Additional studies validating our results with a longer follow-up are necessary.…”
Section: Discussioncontrasting
confidence: 57%
“… 24 Although the reason for this outcome was not determined in this study, peripheral immune activation after CIRT may be responsible. 25 Despite differences in background and evaluation methods between the previous studies and our study, our findings indicate that CIRT could be a promising treatment option for nmCRPC. Additional studies validating our results with a longer follow-up are necessary.…”
Section: Discussioncontrasting
confidence: 57%
“…CIRT has the potential to elicit immune activation of lymphocytes, such as T cells, NK cells, and DCs; increase lymphocyte proliferation; enhance lymphocyte functionality; limiting the induction of immunosuppressive cells such as myeloid-derived suppressor cells (MDSCs); and reduce the expression of immunosuppressive cytokines. Hu et al 21 assessed the immune response evoked by CIRT in 32 patients with localized prostate cancer, and the results showed that there were no significant differences in the frequencies of CD3 + , CD4 + , CD8 + T cells, and NK cells, whereas the CD4/CD8 ratio increased in all lymphocyte subsets except regulatory T cell (Tregs) proliferation and T cell functionality enhancement. However, we did not observe any changes in the MDSCs.…”
Section: The Effects Of Cirt On the Immune Systemmentioning
confidence: 99%
“…Similar results were seen in 32 patients undergoing carbon ion therapy for prostate cancer whereby circulating CD4+ and CD8+ lymphocytes, as well as natural killer cells, were elevated after carbon ion therapy but not after proton therapy. The production of pro‐inflammatory cytokines and the proliferation of these immune cells was also increased following carbon ion therapy 28 . The influx of pro‐inflammatory immune cells often accompanies immunosuppressive cells, such as myeloid‐derived suppressor cells (MDSCs), which inhibit T cell function and enhance the proliferation and differentiation of malignant cells.…”
Section: Immune Activation With Particle Therapymentioning
confidence: 99%
“…The production of pro‐inflammatory cytokines and the proliferation of these immune cells was also increased following carbon ion therapy. 28 The influx of pro‐inflammatory immune cells often accompanies immunosuppressive cells, such as myeloid‐derived suppressor cells (MDSCs), which inhibit T cell function and enhance the proliferation and differentiation of malignant cells. In murine melanoma, tumour irradiation with carbon ions decreased the number of circulating, splenic and intratumoural MDSCs when compared with photon radiation or no treatment.…”
Section: Immune Activation With Particle Therapymentioning
confidence: 99%